149 related articles for article (PubMed ID: 38065067)
1. Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa.
Hirami Y; Mandai M; Sugita S; Maeda A; Maeda T; Yamamoto M; Uyama H; Yokota S; Fujihara M; Igeta M; Daimon T; Fujita K; Ito T; Shibatani N; Morinaga C; Hayama T; Nakamura A; Ueyama K; Ono K; Ohara H; Fujiwara M; Yamasaki S; Watari K; Bando K; Kawabe K; Ikeda A; Kimura T; Kuwahara A; Takahashi M; Kurimoto Y
Cell Stem Cell; 2023 Dec; 30(12):1585-1596.e6. PubMed ID: 38065067
[TBL] [Abstract][Full Text] [Related]
2. Turning point of organoid transplantation: first-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa.
Zhang CJ; Jin ZB
Sci China Life Sci; 2024 May; 67(5):1082-1084. PubMed ID: 38332215
[No Abstract] [Full Text] [Related]
3. [Toward establishment of regenerative cell therapy for retinitis pigmentosa using iPS cell derived retinal sheet].
Akiba R; Matsuyama T; Takahashi M; Mandai M
Nihon Yakurigaku Zasshi; 2020; 155(2):93-98. PubMed ID: 32115485
[TBL] [Abstract][Full Text] [Related]
4. Generation of Human Patient iPSC-derived Retinal Organoids to Model Retinitis Pigmentosa.
Ma C; Jin K; Jin ZB
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35786611
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients.
Liu Y; Chen SJ; Li SY; Qu LH; Meng XH; Wang Y; Xu HW; Liang ZQ; Yin ZQ
Stem Cell Res Ther; 2017 Sep; 8(1):209. PubMed ID: 28962643
[TBL] [Abstract][Full Text] [Related]
6. Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.
Deng WL; Gao ML; Lei XL; Lv JN; Zhao H; He KW; Xia XX; Li LY; Chen YC; Li YP; Pan D; Xue T; Jin ZB
Stem Cell Reports; 2018 Apr; 10(4):1267-1281. PubMed ID: 29526738
[TBL] [Abstract][Full Text] [Related]
7. Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids.
Lane A; Jovanovic K; Shortall C; Ottaviani D; Panes AB; Schwarz N; Guarascio R; Hayes MJ; Palfi A; Chadderton N; Farrar GJ; Hardcastle AJ; Cheetham ME
Stem Cell Reports; 2020 Jul; 15(1):67-79. PubMed ID: 32531192
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.
Li Y; Tsai YT; Hsu CW; Erol D; Yang J; Wu WH; Davis RJ; Egli D; Tsang SH
Mol Med; 2012 Dec; 18(1):1312-9. PubMed ID: 22895806
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of Human Induced Pluripotent Stem Cell-Derived Retinal Progenitor Cell Grafts in Immunocompromised Rats.
Han IC; Bohrer LR; Gibson-Corley KN; Wiley LA; Shrestha A; Harman BE; Jiao C; Sohn EH; Wendland R; Allen BN; Worthington KS; Mullins RF; Stone EM; Tucker BA
Cell Transplant; 2022; 31():9636897221104451. PubMed ID: 35758274
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model.
Tsuchida T; Murata S; Hasegawa S; Mikami S; Enosawa S; Hsu HC; Fukuda A; Okamoto S; Mori A; Matsuo M; Kawakatsu Y; Matsunari H; Nakano K; Nagashima H; Taniguchi H
Cell Transplant; 2020; 29():963689720964384. PubMed ID: 33103476
[TBL] [Abstract][Full Text] [Related]
11. Pluripotent stem cell therapy for retinal diseases.
Ahmed I; Johnston RJ; Singh MS
Ann Transl Med; 2021 Aug; 9(15):1279. PubMed ID: 34532416
[TBL] [Abstract][Full Text] [Related]
12. Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa.
Radtke ND; Aramant RB; Seiler MJ; Petry HM; Pidwell D
Arch Ophthalmol; 2004 Aug; 122(8):1159-65. PubMed ID: 15302656
[TBL] [Abstract][Full Text] [Related]
13. Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases.
Liang Y; Sun X; Duan C; Tang S; Chen J
Stem Cell Res Ther; 2023 Nov; 14(1):340. PubMed ID: 38012786
[TBL] [Abstract][Full Text] [Related]
14. Organoid technology for retinal repair.
Llonch S; Carido M; Ader M
Dev Biol; 2018 Jan; 433(2):132-143. PubMed ID: 29291970
[TBL] [Abstract][Full Text] [Related]
15. Retinal organoids provide unique insights into molecular signatures of inherited retinal disease throughout retinogenesis.
Watson A; Lako M
J Anat; 2023 Aug; 243(2):186-203. PubMed ID: 36177499
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent stem cell-derived retinal organoid/cells for retinal regeneration therapies: A review.
Mandai M
Regen Ther; 2023 Mar; 22():59-67. PubMed ID: 36712956
[TBL] [Abstract][Full Text] [Related]
17. Stem cell transplantation as a progressing treatment for retinitis pigmentosa.
Hosseini Shabanan S; Seyedmirzaei H; Barnea A; Hanaei S; Rezaei N
Cell Tissue Res; 2022 Feb; 387(2):177-205. PubMed ID: 35001210
[TBL] [Abstract][Full Text] [Related]
18. Patient-specific induced pluripotent stem cells to evaluate the pathophysiology of TRNT1-associated Retinitis pigmentosa.
Sharma TP; Wiley LA; Whitmore SS; Anfinson KR; Cranston CM; Oppedal DJ; Daggett HT; Mullins RF; Tucker BA; Stone EM
Stem Cell Res; 2017 May; 21():58-70. PubMed ID: 28390992
[TBL] [Abstract][Full Text] [Related]
19. Modeling Retinitis Pigmentosa with Patient-Derived iPSCs.
Leong YC; Sowden JC
Adv Exp Med Biol; 2023; 1415():555-563. PubMed ID: 37440086
[TBL] [Abstract][Full Text] [Related]
20. Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: A pluripotent stem cell-based approach.
Gagliardi G; Ben M'Barek K; Goureau O
Prog Retin Eye Res; 2019 Jul; 71():1-25. PubMed ID: 30885665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
